Clinical insight-driven micron-sized cholesterol oxidation platform for membrane lipid therapy of advanced ovarian cancer
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.This study introduces a novel cholesterol oxidation therapy using PLGA microspheres to treat drug-resistant ovarian cancer. The treatment enhanced chemosensitivity and reduced tumor progression with fewer side effects.
Area Of Science
- Oncology
- Biomedical Engineering
- Nanotechnology
Background
- Ovarian cancer is often diagnosed at advanced stages with drug resistance, limiting survival rates.
- Cholesterol levels correlate with ovarian cancer progression, suggesting targeting cell membranes is a viable therapeutic strategy.
Purpose Of The Study
- To develop and evaluate a novel cholesterol oxidation-mediated membrane lipid therapy for drug-resistant advanced ovarian cancer.
- To investigate the efficacy of PLGA microspheres co-loaded with miriplatin and cholesterol oxidase in vitro and in vivo.
Main Methods
- PLGA microspheres co-encapsulating miriplatin (MiR) and cholesterol oxidase (COD) were prepared and characterized.
- In vitro studies assessed cholesterol oxidation effects on cell membrane properties, mitochondrial function, and chemosensitivity in SKOV3-TR cells.
- In vivo studies evaluated the therapeutic efficacy and safety of the formulation in a drug-resistant metastatic ovarian cancer model.
Main Results
- COD-induced cholesterol oxidation altered membrane rigidity/fluidity, reduced tumor cell migration, and disrupted mitochondrial function.
- The therapy enhanced chemosensitivity by reducing drug resistance proteins and induced apoptosis in resistant cells.
- In vivo studies showed significant reduction in metastasis, tumor destruction, prolonged survival, and decreased chemotherapy side effects.
Conclusions
- Cholesterol oxidation-mediated membrane lipid therapy using PLGA microspheres is a promising strategy for treating advanced, drug-resistant ovarian cancer.
- This approach offers a potential way to overcome platinum resistance and reduce treatment toxicity.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...